Analyst Consensus ?
ConsensusBuy41 ratings
Bullish3585.4%
Neutral614.6%
Bearish00.0%
FN2 Earnings Intelligence
CVS Health Corp. complete analyst coverage
CVS Health Corp. (CVS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$92.53Previous close
$66Low
$107.16Average
$126High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Leerink Partners | Outperform | Outperform | Maintain | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Sep 3, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 7, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 23, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 4, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 11, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 15, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 31, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 30, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 3, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | May 2, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 12, 2023 |
| Edward Jones | Hold | Buy | Downgrade | Aug 18, 2023 |
| Raymond James | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 8, 2023 |
| Tigress Financial | Buy | Buy | Maintain | Dec 23, 2021 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 19, 2021 |
| Guggenheim | Neutral | Buy | Downgrade | Mar 17, 2021 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Dec 14, 2020 |
| Citigroup | Buy | Buy | Maintain | May 7, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 13, 2020 |
| CFRA | Strong Buy | Strong Buy | Maintain | Feb 13, 2020 |
| Citi | Buy | Buy | Maintain | Nov 7, 2019 |
| Bank of America | Buy | Buy | Maintain | Sep 12, 2019 |
| Oppenheimer | Perform | Outperform | Downgrade | Apr 15, 2019 |
| Leerink Swann | Outperform | Outperform | Maintain | Feb 9, 2018 |
| Needham | Buy | Hold | Upgrade | Nov 10, 2017 |
| Loop Capital | Hold | Hold | Maintain | Nov 7, 2017 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 10, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Nov 5, 2014 |
| ISI Group | Strong Buy | Buy | Upgrade | Jan 22, 2014 |
| Macquarie | Outperform | Neutral | Upgrade | Dec 14, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $92.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Leerink Partners | Analyst unavailable | $112 | $86.16 | +21.0% | Oct 12, 2026 |
| Piper Sandler | Analyst unavailable | $112 | $93.04 | +21.0% | Sep 9, 2026 |
| UBS | Analyst unavailable | $118 | $97.23 | +27.5% | Sep 3, 2026 |
| Argus Research | Analyst unavailable | $114 | $95.58 | +23.2% | Aug 19, 2026 |
| Robert W. Baird | Michael Ha | $107 | $96.96 | +15.6% | Aug 6, 2026 |
| UBS | Kevin Caliendo | $126 | $99.12 | +36.2% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $108 | $99.12 | +16.7% | Aug 6, 2026 |
| UBS | Analyst unavailable | $122 | $107.85 | +31.8% | Jul 24, 2026 |
| Truist Financial | David MacDonald | $118 | $105.9 | +27.5% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $123 | $104.15 | +32.9% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $113 | $104.83 | +22.1% | Jul 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $110 | $102.08 | +18.9% | Jul 7, 2026 |
| HSBC | Analyst unavailable | $103 | $102.28 | +11.3% | Jul 6, 2026 |
| Mizuho Securities | Analyst unavailable | $115 | $95.93 | +24.3% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $111 | $91.37 | +20.0% | Jun 4, 2026 |
| Truist Financial | Analyst unavailable | $108 | $90.98 | +16.7% | Jun 1, 2026 |
| Piper Sandler | Jessica Tassan | $113 | $90.98 | +22.1% | Jun 1, 2026 |
| Barclays | Andrew Mok | $106 | $91.63 | +14.6% | May 26, 2026 |
| Mizuho Securities | Analyst unavailable | $110 | $94.18 | +18.9% | May 20, 2026 |
| Morgan Stanley | Analyst unavailable | $106 | $97.85 | +14.6% | May 14, 2026 |
| Bernstein | Analyst unavailable | $106 | $95.15 | +14.6% | May 13, 2026 |
| RBC Capital | Analyst unavailable | $107 | $86.56 | +15.6% | May 7, 2026 |
| Deutsche Bank | Analyst unavailable | $92 | $87.46 | -0.6% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $102 | $87.04 | +10.2% | May 7, 2026 |
| Barclays | Andrew Mok | $101 | $86.86 | +9.2% | May 7, 2026 |
| Robert W. Baird | Analyst unavailable | $94 | $77.62 | +1.6% | Apr 15, 2026 |
| Leerink Partners | Michael Cherny | $98 | $79.49 | +5.9% | Mar 5, 2026 |
| Argus Research | Analyst unavailable | $90 | $73.2 | -2.7% | Jan 28, 2026 |
| Bernstein | Analyst unavailable | $91 | $80.56 | -1.7% | Jan 6, 2026 |
| Bernstein | Analyst unavailable | $87 | $80.84 | -6.0% | Dec 12, 2025 |
| Mizuho Securities | Ann Hynes | $95 | $79.05 | +2.7% | Dec 10, 2025 |
| Robert W. Baird | Analyst unavailable | $92 | $78.24 | -0.6% | Dec 10, 2025 |
| Piper Sandler | Jessica Tassan | $101 | $78.24 | +9.2% | Dec 10, 2025 |
| Morgan Stanley | Analyst unavailable | $93 | $78.24 | +0.5% | Dec 10, 2025 |
| Barclays | Analyst unavailable | $93 | $78.24 | +0.5% | Dec 10, 2025 |
| UBS | Kevin Caliendo | $97 | $78.24 | +4.8% | Dec 10, 2025 |
| Truist Financial | Analyst unavailable | $100 | $78.24 | +8.1% | Dec 10, 2025 |
| Bernstein | Analyst unavailable | $86 | $76.75 | -7.1% | Dec 4, 2025 |
| RBC Capital | Analyst unavailable | $93 | $77.56 | +0.5% | Oct 30, 2025 |
| UBS | Analyst unavailable | $96 | $81.07 | +3.8% | Oct 24, 2025 |
| Truist Financial | David MacDonald | $92 | $79.26 | -0.6% | Oct 14, 2025 |
| Morgan Stanley | Erin Wright | $89 | $78.82 | -3.8% | Oct 14, 2025 |
| Goldman Sachs | Analyst unavailable | $91 | $78.44 | -1.7% | Oct 14, 2025 |
| Mizuho Securities | Ann Hynes | $88 | $76.93 | -4.9% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $103 | $76.84 | +11.3% | Oct 7, 2025 |
| Barclays | Andrew Mok | $87 | $73.32 | -6.0% | Sep 4, 2025 |
| UBS | Kevin Caliendo | $79 | $68.6 | -14.6% | Aug 18, 2025 |
| Robert W. Baird | Michael Ha | $82 | $66.58 | -11.4% | Aug 14, 2025 |
| Barclays | Andrew Mok | $79 | $63.6 | -14.6% | Jun 2, 2025 |
| Argus Research | Analyst unavailable | $77 | $65.57 | -16.8% | Feb 18, 2025 |
| Deutsche Bank | George Hill | $66 | $59.08 | -28.7% | Dec 3, 2024 |
| Wells Fargo | Stephen Baxter | $66 | $57.11 | -28.7% | Nov 18, 2024 |
| Mizuho Securities | Ann Hynes | $66 | $57.04 | -28.7% | Oct 24, 2024 |
| Truist Financial | David MacDonald | $76 | $58.2 | -17.9% | Oct 21, 2024 |
| Piper Sandler | Jessica Tassan | $72 | $59.15 | -22.2% | Oct 21, 2024 |
| Barclays | Andrew Mok | $82 | $66.63 | -11.4% | Oct 10, 2024 |
| Deutsche Bank | George Hill | $63 | $57.85 | -31.9% | Aug 8, 2024 |
| J.P. Morgan | Lisa Gill | $86 | $58.58 | -7.1% | Jun 28, 2024 |
| Barclays | Andrew Mok | $65 | $61.01 | -29.8% | Jun 20, 2024 |
| RBC Capital | Anton Hie | $68 | $56.31 | -26.5% | May 2, 2024 |
| Piper Sandler | Jessica Tassan | $94 | $77.4 | +1.6% | Mar 15, 2024 |
| Morgan Stanley | Erin Wright | $100 | $73.76 | +8.1% | Dec 12, 2023 |
| Truist Financial | David Macdonald | $98 | $70.52 | +5.9% | Sep 13, 2023 |
| Wolfe Research | Justin Lake | $80 | $70.52 | -13.5% | Sep 12, 2023 |
| Truist Financial | David Macdonald | $103 | $71.27 | +11.3% | Jul 12, 2023 |
| Morgan Stanley | Analyst unavailable | $120 | $89.18 | +29.7% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $101 | $92.91 | +9.2% | Jan 3, 2023 |
| Evercore ISI | Analyst unavailable | $100 | $93.19 | +8.1% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $119 | $100.22 | +28.6% | Nov 23, 2022 |
| Evercore ISI | Analyst unavailable | $125 | $100.52 | +35.1% | Sep 7, 2022 |
| Mizuho Securities | Analyst unavailable | $120 | $106.39 | +29.7% | Aug 15, 2022 |
| Deutsche Bank | George Hill | $120 | $106.39 | +29.7% | Aug 14, 2022 |
| Credit Suisse | Analyst unavailable | $117 | $102.26 | +26.4% | Aug 8, 2022 |
| UBS | Analyst unavailable | $127 | $103.14 | +37.3% | Aug 4, 2022 |
| Deutsche Bank | Analyst unavailable | $113 | $97.73 | +22.1% | May 5, 2022 |
| Tigress Financial | Ivan Feinseth | $125 | $104.45 | +35.1% | Apr 11, 2022 |
| Deutsche Bank | George Hill | $110 | $102.13 | +18.9% | Feb 21, 2022 |
| BMO Capital | Matt Borsch | $120 | $104.24 | +29.7% | Feb 13, 2022 |
| Goldman Sachs | Nathan Rich | $121 | $104.79 | +30.8% | Feb 9, 2022 |
| RBC Capital | Ben Hendrix | $119 | $104.79 | +28.6% | Feb 9, 2022 |
| Jefferies | Brian Tanquilut | $120 | $102.39 | +29.7% | Jan 20, 2022 |
| Bank of America Securities | Michael Cherny | $117 | $106.22 | +26.4% | Jan 16, 2022 |
| Bernstein | Lance Wilkes | $116 | $105.48 | +25.4% | Jan 11, 2022 |
| Wells Fargo | Steve Baxter | $111 | $102.04 | +20.0% | Jan 6, 2022 |
| Truist Financial | David S Macdonald | $124 | $105.25 | +34.0% | Jan 5, 2022 |
| Morgan Stanley | Ricky Goldwasser | $125 | $98.37 | +35.1% | Dec 13, 2021 |
| Cowen & Co. | Charles Rhyee | $114 | $98.33 | +23.2% | Dec 10, 2021 |
| Credit Suisse | A.J. Rice | $120 | $98.33 | +29.7% | Dec 10, 2021 |
| Seaport Global | Joseph France | $110 | $88.31 | +18.9% | Dec 1, 2021 |
| UBS | Kevin Caliendo | $106 | $93.71 | +14.6% | Nov 11, 2021 |
| Cantor Fitzgerald | Steven Halper | $115 | $95.83 | +24.3% | Nov 3, 2021 |
| Wolfe Research | Justin Lake | $93 | $87.69 | +0.5% | May 19, 2021 |
Track every rating change on CVS the moment it posts. Free to start.
Start freeGet the CVS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.